Search details
1.
Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.
PLoS One
; 11(2): e0148264, 2016.
Article
in English
| MEDLINE | ID: mdl-26849574
2.
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.
Orphanet J Rare Dis
; 9: 199, 2014 Dec 18.
Article
in English
| MEDLINE | ID: mdl-25519680
3.
Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.
Orphanet J Rare Dis
; 11(1): 92, 2016 Jul 07.
Article
in English
| MEDLINE | ID: mdl-27387831
Results
1 -
3
de 3
1
Next >
>>